Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized TrialXavier Sáez‐Llorens, Nicolas Vanhoutte, Jerzy Brzostek et al.|The Journal of Infectious Diseases|2023Cited by 13
Incidence of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 PandemicSamantha Fry, Gaël Dos Santos, Kulkanya Chokephaibulkit et al.|Open Forum Infectious Diseases|2023Cited by 3
A multicountry study to establish rates for pregnancy and neonatal outcomes in low- and middle-income regionsAntonella N. Tullio, Gaël Dos Santos, Emad Yanni et al.|Figshare|2026Cited by 0
Additional file 1 of A multicountry study to establish rates for pregnancy and neonatal outcomes in low- and middle-income regionsAntonella N. Tullio, Gaël Dos Santos, Emad Yanni et al.|Figshare|2026Cited by 0